These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26989127)

  • 1. Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report.
    Armstrong TS; Bishof AM; Brown PD; Klein M; Taphoorn MJ; Theodore-Oklota C
    Neuro Oncol; 2016 Mar; 18 Suppl 2(Suppl 2):ii1-ii12. PubMed ID: 26989127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pattern of care of high-grade gliomas].
    Laigle-Donadey F; Sanson M
    Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations.
    Blakeley JO; Coons SJ; Corboy JR; Kline Leidy N; Mendoza TR; Wefel JS
    Neuro Oncol; 2016 Mar; 18 Suppl 2(Suppl 2):ii13-ii20. PubMed ID: 26989128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of resection for newly diagnosed malignant gliomas.
    Schiff D; Shaffrey ME
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):621-30. PubMed ID: 14599086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of adult glioma is multiphasic].
    Mäenpää HO
    Duodecim; 2010; 126(14):1669-75. PubMed ID: 20804085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnosis of multiple gliomas, multicentric gliomas and the other main endocranial multifocal lesions. Presentation of a case].
    Salvati M; Ferrari M; Fiorenza F; Ramundo EO; Artico M; Cosentino F; Cosentino F
    G Ital Oncol; 1989; 9(4):135-40. PubMed ID: 2559028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnosis of brain gliomas by positron emission tomography using various radiopharmaceuticals].
    Kostenikov NA; Tiutin LA; Fadeev NP; Panfilenko AF; Zykov EM; Iliushchenko IuR; Makeeva OIu
    Vestn Rentgenol Radiol; 2014; (5):13-8. PubMed ID: 25775890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions.
    Gagliardi F; Narayanan A; Reni M; Franzin A; Mazza E; Boari N; Bailo M; Zordan P; Mortini P
    Glia; 2014 Jul; 62(7):1015-23. PubMed ID: 24715652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent high-grade glioma: a diagnostic and therapeutic challenge.
    Walbert T; Mikkelsen T
    Expert Rev Neurother; 2011 Apr; 11(4):509-18. PubMed ID: 21469924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient.
    Cochereau J; Herbet G; Rigau V; Duffau H
    J Neurosurg; 2016 Jan; 124(1):141-5. PubMed ID: 26162036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological behavior of the primitive neuroectodermal tumors: significant supratentorial childhood gliomas.
    Parker JC; Mortara RH; McCloskey JJ
    Surg Neurol; 1975 Oct; 4(4):383-8. PubMed ID: 170697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temozolomide in malignant gliomas.
    Yung WK
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
    Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
    Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas.
    Galanis E; Buckner JC; Novotny P; Morton RF; McGinnis WL; Dinapoli R; Schomberg P; O'Fallon JR
    J Neurosurg; 2000 Aug; 93(2):201-7. PubMed ID: 10930004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
    Narita Y
    Jpn J Clin Oncol; 2013 Jun; 43(6):587-95. PubMed ID: 23585688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal or non-diagnostic neuroimaging studies prior to the detection of malignant primary brain tumors.
    Thaler PB; Li JY; Isakov Y; Black KS; Schulder M; Demopoulos A
    J Clin Neurosci; 2012 Mar; 19(3):411-4. PubMed ID: 22277560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.